Organ preservation in rectal cancer: have all questions been answered?

Lancet Oncol. 2015 Jan;16(1):e13-22. doi: 10.1016/S1470-2045(14)70398-5. Epub 2014 Dec 29.

Abstract

Improved treatment strategies have eliminated local control as the major problem in rectal cancer. With increasing awareness of long-term toxic effects in survivors of rectal cancer, organ-preservation strategies are becoming more popular. After chemoradiotherapy, both watchful waiting and local excision are used as possible alternatives for radical surgery. Although these seem attractive strategies, many issues about the safety of organ preservation remain. Additionally, radiotherapy strategies are mainly aimed at intermediate and high-risk rectal tumours, and adaptation of this standard practice for a completely new treatment indication has yet to start. This Review will discuss the options and problems of organ preservation, and address the research questions that need to be answered in the coming years, with a specific focus on radiotherapy.

Publication types

  • Review

MeSH terms

  • Chemoradiotherapy, Adjuvant
  • Chemotherapy, Adjuvant
  • Digestive System Surgical Procedures* / adverse effects
  • Humans
  • Minimally Invasive Surgical Procedures
  • Neoadjuvant Therapy* / adverse effects
  • Neoplasm, Residual
  • Organ Sparing Treatments / adverse effects
  • Organ Sparing Treatments / methods*
  • Patient Selection
  • Radiotherapy, Adjuvant
  • Rectal Neoplasms / pathology
  • Rectal Neoplasms / radiotherapy
  • Rectal Neoplasms / therapy*
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome